Bleeding News and Research

RSS

Updated data on XL184 study in patients with glioblastoma multiforme presented

Exelixis, Inc. and Bristol-Myers Squibb Company today reported updated phase 2 clinical data which show that XL184 demonstrated activity in patients with glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer.

24 Oct 2009

Philippines calls for help to address disease outbreak in storms' aftermath

The WHO on Thursday said the Philippines is requesting "international help to fight a deadly outbreak of an infectious disease following two devastating tropical storms," Agence France-Presse reports. Parts of Manila, which are still flooded almost four weeks after Tropical Storm Ketsana hit, are experiencing an outbreak of the bacterial infection, leptospirosis (10/22).

24 Oct 2009

Combination treatement for IVF patients may eliminate vaginal bleeding

A prospective, multi-center study demonstrated that in IVF (in vitro fertilization) cycles supplemented with once-daily dosing of Crinone® vaginal progesterone gel and Estrace® oral estrogen, vaginal bleeding is rare in patients who become pregnant. Bleeding does occur in approximately one-quarter of patients who do not become pregnant. These data were presented at the American Society for Reproductive Medicine (ASRM) annual meeting in Atlanta.

23 Oct 2009

Rosetta Genomics, GTG sign exclusive distribution agreement

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, and Genetic Technologies Limited (GTG), the leading private genetic testing laboratory in Australia, announced today the signing of an exclusive distribution agreement for Rosetta Genomics’ three currently available diagnostic tests.

22 Oct 2009

Bristol-Myers Squibb reports strong sales and earnings growth for third quarter 2009

Bristol-Myers Squibb Company today reported strong sales and earnings growth for the third quarter 2009.

22 Oct 2009

Comparative Effectiveness Research: One way to beat the competition

A higher percentage of companies are using Comparative Effectiveness Research to help with pricing and reimbursement decisions, according to new research from Cutting Edge Information.

21 Oct 2009

First human implants of the Conformable GORE TAG Thoracic Endoprosthesis performed

W. L. Gore & Associates (Gore) today announced the first human implants of the next generation Conformable GORE TAG® Thoracic Endoprosthesis for the treatment of thoracic aortic aneurysms (TAAs). The first implants were performed by Joshua Rovin, MD and Eugene Murphy, MD, at Bayfront Medical Center and William McMillan, MD and Scott Schultz, MD, at North Memorial Medical Center.

21 Oct 2009

RA patients who adhere to their prescription drug regimen have better outcome: Study

Rheumatoid arthritis (RA) patients who regularly adhere to their prescription drug regimen have fewer emergency room and doctor visits and incur lower medical costs, according to research presented today by Medco Health Solutions, Inc. at the American College of Rheumatology's Annual Meeting in Philadelphia.

20 Oct 2009

Physicians say thyroid surgery safe for older people

Thyroid surgery is safe for older patients, say physicians who found only slight differences in rates of complications and hospital readmissions in a multi-year study.

20 Oct 2009

Cumberland Pharmaceuticals publishes data on its Phase III intravenous ibuprofen study

Cumberland Pharmaceuticals Inc. announced today that its Phase III study on intravenous ibuprofen as a post-operative analgesic was published in Volume 31, Number 9 of the peer-reviewed journal Clinical Therapeutics, distributed in October. The study concludes that patients emerging from orthopedic and abdominal surgeries required less narcotic and experienced less pain with 800 mg of intravenous ibuprofen every six hours compared to morphine alone.

20 Oct 2009

Biogen Idec and Biovitrum to conduct rFIXFc clinical trial in hemophilia B patients

Biogen Idec and Biovitrum AB (STO: BVT) today announced that they plan to advance the companies’ long-acting, fully-recombinant Factor IX Fc fusion protein (rFIXFc) into a registrational clinical trial in hemophilia B patients.

19 Oct 2009

Laerdal Medical Corporation launches a new Advanced version of the ALS Patient Simulator

Building on the success of the Advanced Life Support (ALS) Patient Simulator and in response to growing interest from emergency care providers across the United States, Laerdal Medical Corporation introduces ALS Simulator Advanced.

From Laerdal 15 Oct 2009

Somanetics obtains exclusive sublicense to new cerebral autoregulation technology

Somanetics Corporation today announced that it has signed an Exclusive Sublicense Agreement with Raba Equity Partners II, LLC ("Raba coreFoundry"). Under terms of the agreement, Somanetics has obtained exclusive rights, subject to specified rights of the U.S. Government and rights retained by The Johns Hopkins University, to new cerebral autoregulation technology developed at The Johns Hopkins University.

15 Oct 2009

CeloNova BioSciences' Embozene Microspheres receives approval

CeloNova BioSciences, Inc. has received approval from its European regulatory body, the British Standards Institution, to expand the list of medical indications for which Embozene(TM) Microspheres may be used and to add a tenth size of the product.

14 Oct 2009

Physicians having less than six hours of sleep linked to increase rate of surgical complications

Attending surgeons and obstetricians/gynecologists who worked nighttime hours did not have a significantly greater rate of complications for procedures performed the next day, but having less than six hours of opportunity for sleep between procedures was associated with an increased rate of surgical complications, according to a study in the October 14 issue of JAMA, a theme issue on surgical care.

14 Oct 2009

H1N1 patients with ARDS survive illness when treated with ECMO

Despite the severity of disease and the intensity of treatment, most patients in Australia and New Zealand who experienced respiratory failure as a result of 2009 influenza A(H1N1) and were treated with a system that adds oxygen to the patient's blood survived the disease, according to a study to appear in the November 4 issue of JAMA.

14 Oct 2009

Bicycle-related injuries on the rise

Record-high gasoline prices, the slowdown in the economy, and increasing environmental sensitivity are leading more people to bike to work or for play. But an adequate infrastructure may not be in place to protect cyclists from serious injury according to surgeons who presented a new study on the issue during a scientific paper session at the 2009 Clinical Congress of the American College of Surgeons.

14 Oct 2009

Do not underestimate the serious impact of the H1N1 virus, say researchers

A research team has warned medical experts in the Northern Hemisphere not to underestimate the serious impact of the H1N1 (Swine flu) virus with a new report showing that many patients who were critically ill with the virus required prolonged life support treatment with heart-lung machines.

14 Oct 2009

OBP Medical launches cost effective, patient friendly disposable briefs

While walking the road to recovery a patient should at all times feel secure and comfortable in the attire provided to them by their healthcare facility. Here to help is OBP Medical Inc.'s Under Johnnies(TM) Brief with Pad: a cost effective, patient friendly, line of disposable briefs with ultra absorbent padding for patients with post operative bleeding or discharge.

13 Oct 2009

NiTi Surgical Solutions to showcase its investigational bowel anastomosis device at the 95th ACS Congress

NiTi™ Surgical Solutions, an innovative surgical device company, today announced that it will showcase its new, investigational bowel anastomosis device this week at the American College of Surgeons (ACS) 95th Annual Clinical Congress in Chicago, Illinois. The device, which will be marketed as BowelRing™, represents the company’s next advancement in its innovative BioDynamix™ Anastomosis Technology platform.

12 Oct 2009

Bleeding News and Research

Updated data on XL184 study in patients with glioblastoma multiforme presented

Philippines calls for help to address disease outbreak in storms' aftermath

Combination treatement for IVF patients may eliminate vaginal bleeding

Rosetta Genomics, GTG sign exclusive distribution agreement

Bristol-Myers Squibb reports strong sales and earnings growth for third quarter 2009

Comparative Effectiveness Research: One way to beat the competition

First human implants of the Conformable GORE TAG Thoracic Endoprosthesis performed

RA patients who adhere to their prescription drug regimen have better outcome: Study

Physicians say thyroid surgery safe for older people

Cumberland Pharmaceuticals publishes data on its Phase III intravenous ibuprofen study

Biogen Idec and Biovitrum to conduct rFIXFc clinical trial in hemophilia B patients

Laerdal Medical Corporation launches a new Advanced version of the ALS Patient Simulator

Somanetics obtains exclusive sublicense to new cerebral autoregulation technology

CeloNova BioSciences' Embozene Microspheres receives approval

Physicians having less than six hours of sleep linked to increase rate of surgical complications

H1N1 patients with ARDS survive illness when treated with ECMO

Bicycle-related injuries on the rise

Do not underestimate the serious impact of the H1N1 virus, say researchers

OBP Medical launches cost effective, patient friendly disposable briefs

NiTi Surgical Solutions to showcase its investigational bowel anastomosis device at the 95th ACS Congress

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News